Concepedia

Mingjun Xu

MX

Statistics

Publications

14

Citations

1.5K

H-Index

11

Active since

2015

Affiliations

Qilu Hospital of Shandong University(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Zhongshan People's Hospital

Sun Yat-sen University

State Key Laboratory of Oncology in South China

Mingjun Xu is an author at Qilu Hospital of Shandong University specializing in medicine, cardiology, and ultrasonography.

ORCID

Publications per year

2015–2025

14

Publications

14

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Li Zhang, Yan Huang, Shaodong Hong et al. · The Lancet · 2016 · 525 citations

, , +11

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

Yunpeng Yang, Song Qu, Jingao Li et al. · The Lancet Oncology · 2021 · 449 citations

, , +12

Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study

Mei Zhang, Yan Liu, Mingjun Xu et al. · Scientific Reports · 2019 · 116 citations · Full text

, , +17

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study

Shaodong Hong, Yaxiong Zhang, Gengsheng Yu et al. · Journal of Clinical Oncology · 2021 · 103 citations · Full text

, , +17

Echocardiographic Measurements in Normal Chinese Adults Focusing on Cardiac Chambers and Great Arteries: A Prospective, Nationwide, and Multicenter Study

Guihua Yao, Yan Deng, Yan Liu et al. · Journal of the American Society of Echocardiography · 2015 · 97 citations

, , +14

1–5 of 14